AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 54 filers reported holding AC IMMUNE SA in Q1 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,000 | -20.0% | 2,777 | -15.8% | 0.00% | – |
| Q2 2023 | $10,000 | +233.3% | 3,299 | +179.6% | 0.00% | – |
| Q1 2023 | $3,000 | +50.0% | 1,180 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | -33.3% | 1,180 | +18.0% | 0.00% | – |
| Q3 2022 | $3,000 | -82.4% | 1,000 | -78.3% | 0.00% | – |
| Q2 2022 | $17,000 | -37.0% | 4,600 | -32.4% | 0.00% | – |
| Q1 2022 | $27,000 | -56.5% | 6,800 | -46.3% | 0.00% | – |
| Q4 2021 | $62,000 | -38.0% | 12,659 | -15.0% | 0.00% | – |
| Q3 2021 | $100,000 | -16.0% | 14,898 | -0.7% | 0.00% | – |
| Q2 2021 | $119,000 | -39.0% | 15,004 | -41.4% | 0.00% | – |
| Q1 2021 | $195,000 | +4775.0% | 25,583 | +2711.3% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 910 | +381.5% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 189 | -61.5% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 491 | +94.1% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 253 | -41.2% | 0.00% | – |
| Q1 2019 | $2,000 | – | 430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
| Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
| Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
| COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
| Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
| Renaissance Technologies | 425,179 | $1,212 | 0.00% |
| Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
| Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |